Ritter Pharmaceuticals basically dead? Короткая

Описание

⋅ 13 сен 2019 г., 13:05

-75% Ritter Pharmaceuticals Inc -after the company's Phase 3 trial of RP-G28 for lactose intolerance failed to demonstrate statistical significance in its pre-specified endpoint

Ещё